Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Youjin Kim, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jong-Mu Sun
Cancer Res Treat. 2019;51(2):502-509.   Published online 2018 Jun 13     DOI: https://doi.org/10.4143/crt.2018.117
Citations to this article as recorded by Crossref logo
Efficacy and safety of afatinib in a Chinese population with advanced lung adenocarcinoma with sensitive EGFR mutations
Shouzheng Wang, Puyuan Xing, Ke Yang, Xuezhi Hao, Di Ma, Yuxin Mu, Junling Li
Thoracic Cancer.2019;[Epub]     CrossRef
Afatinib/gefitinib
Reactions Weekly.2019; 1753(1): 17.     CrossRef